Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
83,427 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Treatment of TinnitusPayerPolicy · BCBSNJ-TREATMENT-017-C544470611 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | AcupuncturePayerPolicy · BCBSNJ-TREATMENT-062-604D725ACA | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Computerized Corneal Topography/VideokeratographyPayerPolicy · BCBSNJ-MEDICINE-003-B49DF42F8D | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Physician Standby ServicePayerPolicy · BCBSNJ-SURGERY-010-062190BE35 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Work Hardening/Conditioning ProgramsPayerPolicy · BCBSNJ-ALLIED-HEALTH-012-981E4803CD | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Strontium-89 Chloride (Metastron)PayerPolicy · BCBSNJ-DRUGS-007-0107C45F14 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Alpha 1-Proteinase Inhibitors (Human) [Prolastin-C, Aralast NP, Zemaira, Glassia]PayerPolicy · BCBSNJ-DRUGS-014-45021456CA | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Spinal Cord and Implantable Peripheral Nerve StimulatorsPayerPolicy · BCBSNJ-SURGERY-067-B12E3BAEC1 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Intravenous Drug Therapy for Multiple SclerosisPayerPolicy · BCBSNJ-DRUGS-038-5C44FBBA01 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Rituximab (Rituxan), Rituximab-abbs (Truxima), Rituximab-pvvr (Ruxience), and Rituximab/hyaluronidase (Rituxan Hycela)PayerPolicy · BCBSNJ-DRUGS-043-F492DC55BC | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Abatacept (Orencia)PayerPolicy · BCBSNJ-DRUGS-042-032BB0E04E | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Interspinous and Interlaminar Stabilization/Distraction Devices (Spacers)PayerPolicy · BCBSNJ-SURGERY-065-7BF38B7335 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Autografts and Allografts in the Treatment of Focal Articular Cartilage LesionsPayerPolicy · BCBSNJ-SURGERY-064-CA3B7B0750 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Bone Morphogenetic ProteinPayerPolicy · BCBSNJ-SURGERY-056-45AF29C2B1 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Assays of Genetic Expression in Tumor Tissue as a Technique to Determine Prognosis in Patients with Breast CancerPayerPolicy · BCBSNJ-MEDICINE-034-120AFCF198 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Transanal Radiofrequency Treatment of Fecal IncontinencePayerPolicy · BCBSNJ-TREATMENT-081-5D664F1B22 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Fluency Enhancing Devices for StutteringPayerPolicy · BCBSNJ-D-M-E-024-11A4B03843 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Clolar (Clofarabine)PayerPolicy · BCBSNJ-DRUGS-037-91C3D866D2 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Occipital Nerve StimulationPayerPolicy · BCBSNJ-SURGERY-060-54357D59B2 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Dynamic Splinting DevicesPayerPolicy · BCBSNJ-D-M-E-027-A5F87FF747 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Implantable Cardioverter Defibrillator (ICD)PayerPolicy · BCBSNJ-SURGERY-061-D8B746BF13 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Sacroiliac Joint ArthrographyPayerPolicy · BCBSNJ-RADIOLOGY-015-F71DF842FF | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Progenitor Cell Therapy for the Treatment of Damaged Myocardium Due to IschemiaPayerPolicy · BCBSNJ-MEDICINE-029-724B8500BF | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Brexucabtagene autoleucel (Tecartus)PayerPolicy · BCBSNJ-DRUGS-211-557AFD47DA | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Inebilizumab-cdon (Uplizna)PayerPolicy · BCBSNJ-DRUGS-210-F1ADA34CD4 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Lurbinectedin (Zepzelca)PayerPolicy · BCBSNJ-DRUGS-209-A031877732 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Afamelanotide (Scenesse)PayerPolicy · BCBSNJ-DRUGS-208-DC967C49EF | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Bimatoprost Implant (Durysta)PayerPolicy · BCBSNJ-DRUGS-207-AE32BF0E1A | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Mitomycin for Pyelocalyceal Solution (Jelmyto)PayerPolicy · BCBSNJ-DRUGS-206-E9A4AEB6C4 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Sacituzumab govitecan-hziy (Trodelvy)PayerPolicy · BCBSNJ-DRUGS-205-8E1FC60470 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Eptinezumab-jjmr (Vyepti)PayerPolicy · BCBSNJ-DRUGS-203-5C937D381C | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Isatuximab-irfc (Sarclisa)PayerPolicy · BCBSNJ-DRUGS-202-47A6C423B3 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Teprotumumab-trbw (Tepezza)PayerPolicy · BCBSNJ-DRUGS-201-06E0D41640 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Enfortumab vedotin-ejfv (Padcev)PayerPolicy · BCBSNJ-DRUGS-200-52E5735908 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Givosiran (Givlaari)PayerPolicy · BCBSNJ-DRUGS-199-9AB4C22BE2 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Crizanlizumab-tmca (Adakveo)PayerPolicy · BCBSNJ-DRUGS-198-09BF92D8E7 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Gemcitabine in sodium chloride injection (Infugem)PayerPolicy · BCBSNJ-DRUGS-197-9A2A0DDA05 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Luspatercept-aamt (Reblozyl)PayerPolicy · BCBSNJ-DRUGS-196-CF98A8E728 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Polatuzumab vedotin-piiq (Polivy)PayerPolicy · BCBSNJ-DRUGS-195-F942AC98E5 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Romosozumab-aqqg (Evenity)PayerPolicy · BCBSNJ-DRUGS-194-A870D79393 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Onasemnogene Abeparvovec (Zolgensma)PayerPolicy · BCBSNJ-DRUGS-193-487D91C39C | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Esketamine (Spravato)PayerPolicy · BCBSNJ-DRUGS-191-316DC2DD46 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Brexanolone (Zulresso)PayerPolicy · BCBSNJ-DRUGS-190-7DC2C85091 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Ixabepilone (Ixempra)PayerPolicy · BCBSNJ-DRUGS-189-C88FA97B11 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Tagraxofusp-erzs (Elzonris)PayerPolicy · BCBSNJ-DRUGS-188-DAE70C3139 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Triamcinolone Acetonide Extended-Release (Zilretta)PayerPolicy · BCBSNJ-DRUGS-181-B68D7DC6B6 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Ibalizumab-uiyk (Trogarzo)PayerPolicy · BCBSNJ-DRUGS-178-1D21FCB9E6 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Hemophilia Products – von Willebrand Factor (von Willebrand Disease): VonvendiPayerPolicy · BCBSNJ-DRUGS-175-2475EE9819 | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Hemophilia Products - Factor VIII (Hemophilia A) and Factor IX (Hemophilia B) with inhibitors, Acquired Hemophilia, Congenital Factor VII Deficiency, and Glanzmann’s Thrombasthenia: Novoseven RT and SevenfactPayerPolicy · BCBSNJ-DRUGS-174-9E4E74480C | New policy |
|---|
| Aug 2, 2026 | Horizon BCBSNJ | Hemophilia Products - Congenital Factor XIII Deficiency: CorifactPayerPolicy · BCBSNJ-DRUGS-173-4660DA8B78 | New policy |
|---|